Department of Health and Human Services September 27, 2022 – Federal Register Recent Federal Regulation Documents
Results 1 - 14 of 14
Listing of Color Additives Exempt From Certification; Calcium Carbonate
The Food and Drug Administration (FDA or we) is amending the color additive regulations to provide for the safe use of calcium carbonate in dietary supplement tablets and capsules. We are taking this action in response to a color additive petition (CAP) submitted by Colorcon, Inc. (Colorcon or petitioner).
Request for Nominations for Voting Members on the Tobacco Products Scientific Advisory Committee
The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Tobacco Products Scientific Advisory Committee, in the Center for Tobacco Products. Nominations will be accepted for upcoming vacancies effective January 31, 2023, with this notice. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups.
Medicaid Program; Temporary Increase in Federal Medical Assistance Percentage (FMAP) in Response to the COVID-19 Public Health Emergency (PHE); Reopening of Public Comment Period
On November 6, 2020, CMS published an interim final rule with request for comments (IFR) entitled ``Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency.'' The IFR set forth certain requirements in CMS regulations that States must follow in order to claim a temporary increase in Federal matching funds for their Medicaid programs under the Families First Coronavirus Response Act (FFCRA). In light of the possibility of changed circumstances since publication of the IFR and other policy considerations, CMS is considering modifying those requirements. CMS is soliciting additional information from the public on any issues that may be pertinent to these potential modifications by reopening the public comment period for an additional 30 days.
Ortho-phthalates for Food Contact Use; Reopening of Comment Period; Request for Information
The Food and Drug Administration (FDA or we) is reopening the comment period for the notice titled ``Ortho-phthalates for Food Contact Use; Request for Information,'' which published in the Federal Register of May 20, 2022. We are taking this action in response to a request from stakeholders to extend the comment period to allow additional time for interested parties to develop and submit data, other information, and comments for this request for information.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.